Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation

Nonalcoholic fatty liver disease (NAFLD) is defined as liver disease in which more than 5% of hepatocytes are steatotic with little or no alcohol consumption. NAFLD includes benign nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Importantly, NASH is an advanced progression o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Chuanrui, Wang, Xinyu, Zhang, Jing, Zhao, Yun, Hua, Yunqing, Zhang, Chao, Zheng, Guobin, Yang, Guangyan, Guan, Jianli, Li, Huahuan, Li, Meng, Kang, Lin, Xiang, Jiaqing, Fan, Guanwei, Yang, Shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239345/
https://www.ncbi.nlm.nih.gov/pubmed/35774609
http://dx.doi.org/10.3389/fphar.2022.893336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239345/
https://www.ncbi.nlm.nih.gov/pubmed/35774609
http://dx.doi.org/10.3389/fphar.2022.893336

Ejemplares similares